Release Date: 23/01/18 09:26 Summary: Vango Secures New Strategic Shareholder Price Sensitive: No Download Document 133.77KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%